ArticlePloS one2021

SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

Marie-Luise Buchholtz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.